A Phase 2 Pilot, Multicenter, Single Arm Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of GSK1070806 Plus Standard of Care for the Prevention of Delayed Graft Function in Adult Subjects After Renal Transplantation
Phase of Trial: Phase II
Latest Information Update: 05 Jun 2017
At a glance
- Drugs GSK 1070806 (Primary)
- Indications Delayed graft function
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 05 Apr 2017 Planned End Date changed from 25 May 2018 to 23 Nov 2018.
- 05 Apr 2017 Planned primary completion date changed from 2 Jun 2017 to 1 Dec 2017.
- 29 Mar 2017 This trial has been suspended in Spain as per European Clinical Trials Database record.